These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 15602503)

  • 21. Micro/kappa opioid interactions in rhesus monkeys: implications for analgesia and abuse liability.
    Negus SS; Schrode K; Stevenson GW
    Exp Clin Psychopharmacol; 2008 Oct; 16(5):386-99. PubMed ID: 18837635
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential naltrexone antagonism of hydromorphone and pentazocine effects in human volunteers.
    Preston KL; Bigelow GE
    J Pharmacol Exp Ther; 1993 Feb; 264(2):813-23. PubMed ID: 7679737
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antinociceptive and respiratory effects of nalbuphine in rhesus monkeys.
    Gerak LR; Butelman ER; Woods JH; France CP
    J Pharmacol Exp Ther; 1994 Nov; 271(2):993-9. PubMed ID: 7965822
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Age-related differences in sensitivity to the antinociceptive effects of kappa opioids in adult male rats.
    Smith MA; French AM
    Psychopharmacology (Berl); 2002 Jul; 162(3):255-64. PubMed ID: 12122483
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of mu opioid agonists alone and in combination with cocaine and D-amphetamine in rhesus monkeys trained to discriminate cocaine.
    Negus SS; Gatch MB; Mello NK
    Neuropsychopharmacology; 1998 May; 18(5):325-38. PubMed ID: 9536446
    [TBL] [Abstract][Full Text] [Related]  

  • 26. kappa-Opioid receptor effects of butorphanol in rhesus monkeys.
    Vivian JA; DeYoung MB; Sumpter TL; Traynor JR; Lewis JW; Woods JH
    J Pharmacol Exp Ther; 1999 Jul; 290(1):259-65. PubMed ID: 10381785
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Opioid interactions in rhesus monkeys: effects of delta + mu and delta + kappa agonists on schedule-controlled responding and thermal nociception.
    Stevenson GW; Folk JE; Linsenmayer DC; Rice KC; Negus SS
    J Pharmacol Exp Ther; 2003 Dec; 307(3):1054-64. PubMed ID: 14557380
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effects of nalbuphine and butorphanol treatment on cocaine and food self-administration by rhesus monkeys.
    Mello NK; Kamien JB; Lukas SE; Drieze J; Mendelson JH
    Neuropsychopharmacology; 1993 Jan; 8(1):45-55. PubMed ID: 8381011
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The kappa opioid nalbuphine produces gender- and dose-dependent analgesia and antianalgesia in patients with postoperative pain.
    Gear RW; Miaskowski C; Gordon NC; Paul SM; Heller PH; Levine JD
    Pain; 1999 Nov; 83(2):339-45. PubMed ID: 10534607
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of bromocriptine pretreatment on subjective and physiological responses to i.v. cocaine.
    Kumor K; Sherer M; Jaffe J
    Pharmacol Biochem Behav; 1989 Aug; 33(4):829-37. PubMed ID: 2616602
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antinociceptive effects of cocaine/opioid combinations in rhesus monkeys.
    Gatch MB; Negus SS; Butelman ER; Mello NK
    J Pharmacol Exp Ther; 1995 Dec; 275(3):1346-54. PubMed ID: 8531102
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enadoline discrimination in squirrel monkeys: effects of opioid agonists and antagonists.
    Carey GJ; Bergman J
    J Pharmacol Exp Ther; 2001 Apr; 297(1):215-23. PubMed ID: 11259547
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effectiveness of nalbuphine, a κ-opioid receptor agonist and μ-opioid receptor antagonist, in the inhibition of I
    Liu YY; Hsiao HT; Wang JC; Liu YC; Wu SN
    Drug Dev Res; 2019 Sep; 80(6):846-856. PubMed ID: 31301190
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The cardiovascular and subjective effects of intravenous cocaine and morphine combinations in humans.
    Foltin RW; Fischman MW
    J Pharmacol Exp Ther; 1992 May; 261(2):623-32. PubMed ID: 1578376
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of mu- and kappa-opioid receptors in cocaine-induced conditioned place preference.
    Suzuki T; Shiozaki Y; Masukawa Y; Misawa M; Nagase H
    Jpn J Pharmacol; 1992 Apr; 58(4):435-42. PubMed ID: 1328733
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential effects of mu and kappa opioid analgesics on cerebral glucose utilization in the rat.
    Fanelli RJ; Szikszay M; Jasinski DR; London ED
    Brain Res; 1987 Oct; 422(2):257-66. PubMed ID: 2445439
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reducing cardiovascular responses to laryngoscopy and tracheal intubation: a comparison of equipotent doses of tramadol, nalbuphine and pethidine, with placebo.
    van den Berg AA; Halliday EM; Soomro NA; Rasheed A; Baloch M
    Middle East J Anaesthesiol; 2004 Oct; 17(6):1023-36. PubMed ID: 15651510
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of chronic morphine on behavior reinforced by several opioids or by cocaine in rhesus monkeys.
    Winger G; Woods JH
    Drug Alcohol Depend; 2001 May; 62(3):181-9. PubMed ID: 11295322
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nalbuphine.
    Schmidt WK; Tam SW; Shotzberger GS; Smith DH; Clark R; Vernier VG
    Drug Alcohol Depend; 1985 Feb; 14(3-4):339-62. PubMed ID: 2986929
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Treatment of postoperative shivering with nalbuphine].
    Götz E; Bogosyan S; Müller E; Litz R
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1995 Feb; 30(1):28-31. PubMed ID: 7888516
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.